Evolutionary-based predictions imply that the premenstrual syndrome (PMS) affects women who failed to conceive while in biosocial conditions that allow immediate reproduction. We investigated how the PMS is related to the heart rate variability (HRV), a marker of general fitness and well-being. The HRV indices (SDNN and rMSSD) were calculated using resting ECGs of 113 physiologically fertile women and 64 women using hormonal contraception (HC users, HCu). The intensity of PMS symptoms was self-assessed (Shortened Premenstrual Assessment Form). Analyses were conducted using parametric and nonparametric tests and general linear modelling (GLM). In HC non-users (HCnu), a greater intensity of PMS symptoms was significantly associated with higher values of HRV. Similar relations were not present in HCu. Post-hoc GLM confirmed that the relation between the PMS intensity and HRV indices varies as a function of the HCu status. A positive association between the PMS intensity and high HRV indices in women who did not use HC may confirm that the PMS affects fertile women who did not conceive, despite being in conditions favorable to pregnancy. The absence of a similar link in HCu women implies that synthetic steroids may disturb the link between the PMS and functioning of the autonomic nervous system.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
L. Dennerstein, P. Lehert, and K. Heinemann, “Global epidemiological study of variation of premenstrual symptoms with age and sociodemographic factors,” Menopause Int., 17, No. 3, 96–101 (2011), doi: https://doi.org/10.1258/mi.2011.011028.
L. Dennerstein, P. Lehert, and K. Heinemann, “Global study of women’s experiences of premenstrual symptoms and their effects on daily life,” Menopause Int., 17, No. 3, 88–95 (2011), doi: https://doi.org/10.1258/mi.2011.011027.
U. Halbreich, T. Backstrom, E. Eriksson, et al., “Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies,” Gynecol. Endocrinol., 23, No. 3, 123–130 (2007), doi: https://doi.org/10.1080/09513590601167969.
K. A. Yonkers, P. M. O’Brien, and E. Eriksson, “Premenstrual syndrome,” Lancet, 371, No. 9619, 1200–1210 (2008), doi: https://doi.org/10.1016/S0140-6736(08)60527-9.
A. Direkvand-Moghadam, K. Sayehmiri, A. Delpisheh, and S. Kaikhavandi, “Epidemiology of premenstrual syndrome (PMS) – A systematic review and metaanalysis study,” J. Clin. Diagn. Res., 8, No. 2, 106–109 (2014), doi: https://doi.org/10.7860/JCDR/2014/8024.4021.
A. J. Rapkin and A. L. Akopians, “Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder,” Menopause Int., 18, No. 2, 52–59 (2012), doi: https://doi.org/10.1258/mi.2012.012014.
H.-U. Wittchen, E. Becker, R. Lieb, and P. Krause, “Prevalence, incidence and stability of premenstrual dysphoric disorder in the community,” Psychol. Med., 32, No. 1, 119–132 (2002).
J. Cunningham, K. A. Yonkers, S. O’Brien, and E. Eriks-son, “Update on research and treatment of premenstrual dysphoric disorder,” Harv. Rev. Psychiatry, 17, No. 2, 120–137 (2009), doi: https://doi.org/10.1080/10673220902891836.
L. Dennerstein, P. Lehert, T. C. Bäckström, and K. Heinemann, “Premenstrual symptoms – severity, duration and typology: an international cross-sectional study,” Menopause Int., 15, No. 3, 120–126 (2009), doi: https://doi.org/10.1258/mi.2009.009030.
C. Henshaw, D. Foreman, J. Belcher, et al., “Can one induce premenstrual symptomatology in women with prior hysterectomy and bilateral oophorectomy?” J. Psychosom. Obstet. Gynaecol., 17, No. 1, 21–28 (1996), doi: https://doi.org/10.3109/01674829609025660.
T. Bäckström, L. Andreen, V. Birzniece, et al., “The role of hormones and hormonal treatments in premenstrual syndrome,” CNS Drugs, 17, No. 5, 325–342 (2003), doi: https://doi.org/10.2165/00023210-200317050-00003.
U. Halbreich, “The etiology, biology, and evolving pathology of premenstrual syndromes,” Psychoneuroendocrinology, 28, Suppl. 3, 55–99 (2003), doi: https://doi.org/10.1016/S0306-4530(03)00097-0.
A. Ryu and T. H. Kim, “Premenstrual syndrome: A mini review,” Maturitas, 82, No. 4, 436–440 (2015), doi: https://doi.org/10.1016/j.maturitas.2015.08.010.
D. K. Kinney and, M. Tanaka, “An evolutionary hypothesis of depression and its symptoms, adaptive value, and risk factors,” J. Nerv. Ment. Dis., 197, No. 8, 561– 567 (2009), doi: https://doi.org/10.1097/NMD.0b013e3181b05fa8.
M. R. Gillings, “Were there evolutionary advantages to premenstrual syndrome?” Evol. Appl., 7, No. 8, 897– 904 (2014), doi: https://doi.org/10.1111/eva.12190.
D. R. Rosseinsky and, P. G. Hall, “Letter: an evolutionary theory of premenstrual tension,” Lancet, 2, No. 7887, 1024 (1974), doi: https://doi.org/10.1016/S0140-6736(74)92132-1.
C. Reiber, “An evolutionary model of premenstrual syndrome,” Med. Hypotheses, 70, No. 5, 1058–1065 (2008), doi: https://doi.org/10.1016/j.mehy.2007.08.031.
R. McCraty and F. Shaffer, “Heart rate variability: New perspectives on physiological mechanisms, assessment of self-regulatory capacity, and health risk,” Glob. Adv. Health Med., 4, No. 1, 46–61 (2015), doi: https://doi.org/10.7453/gahmj.2014.073.
A. Siennicka, D.S. Quintana, P. Fedurek, et al., “Resting heart rate variability, attention and attention maintenance in young adults, “ Int J Psychophysiol.,143:126-131 (2019), doi: 10.1016/j.ijpsycho.2019.06.017.
J. F. Thayer, A. L. Hansen, E. Saus-Rose, and B. H. Johnsen, “Heart rate variability, pre-frontal neural function, and cognitive performance: the neurovisceral integration perspective on self-regulation, adaptation, and health,” Ann. Behav. Med., 37, No. 2, 141–153 (2009), doi: https://doi.org/10.1007/s12160-009-9101-z.
A. Reynard, R. Gevirtz, R. Berlow, et al., “Heart rate variability as a marker of self-regulation,” Appl. Psychophysiol. Biofeedback, 36, No. 3, 209–215. (2011), doi: 10.1007/s10484-011-9162-1.
G. Grandi, S. Ferrari, A. Xholli, et al., “Prevalence of menstrual pain in young women: what is dysmenorrhea?” J. Pain Res., 5, 169–174 (2012), doi: https://doi.org/10.2147/JPR.S30602.
M. A. Farage, S. Neill, and, A. B. MacLean, “Physiological changes associated with the menstrual cycle: a review,” Obstet. Gynecol. Surv., 64, No. 1, 58–72 (2009), doi: https://doi.org/10.1097/OGX.0b013e3181932a37.
J. W. Tukey, Exploratory Data Analysis. Addison-Wesley Reading, PA (1977).
R. Sitruk-Ware and A. Nath, “Metabolic effects of contraceptive steroids,” Rev. Endocr. Metab. Disord., 12, No. 2, 63–75 (2011), doi: https://doi.org/10.1007/s11154-011-9182-4.
M. K. B. Lustyk, W. G. Gerrish, H. Douglas, et al., “Relationships among premenstrual symptom reports, menstrual attitudes, and mindfulness,” Mindfulness (NY), 2, No. 1, 37–48 (2011), doi: https://doi.org/10.1007/s12671-011-0041-x.
A. Rydlewska, E. A. Jankowska, B. Ponikowska, et al., “Changes in autonomic balance in patients with decompensated chronic heart failure,” Clin. Auton. Res., 21, No. 1, 47–54 (2011), doi: https://doi.org/10.1007/s10286-010-0089-z.
“Heart rate variability standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology,” Circulation, 93, No. 5, 1043–1065 (1996), doi: 10.1161/ 01.CIR.93.5.1043.
S. Nieuwenhuis, B. U. Forstmann, and E. J. Wagenmakers, “Erroneous analyses of interactions in neuroscience: a problem of significance,” Nat. Neurosci., 14, No. 9, 1105–1107 (2011), doi: https://doi.org/10.1038/nn.2886.
X. Bai, J. Li, L. Zhou, and X. Li, “Influence of the menstrual cycle on nonlinear properties of heart rate variability in young women,” Am. J. Physiol.. Heart Circ. Physiol., 297, No. 2, H765–H774 (2009), doi: https://doi.org/10.1152/ajpheart.01283.2008.
B. Grrishma, G. S. Gaur, S. Velkumary, et al., “Assessment of cardiovascular autonomic functions and baroreceptor reactivity in women with premenstrual syndrome,” Indian J. Physiol. Pharmacol., 59, No. 2, 148–154 (2015).
P. S. McKinley, A. R. King, P. A. Shapiro, et al., “The impact of menstrual cycle phase on cardiac autonomic regulation,” Psychophysiology, 46, No. 4, 904–911 (2009), doi: https://doi.org/10.1111/j.1469-8986.2009.00811.x.
T. Princi, S. Parco, A. Accardo, et al., “Parametric evaluation of heart rate variability during the menstrual cycle in young women,” Biomed. Sci. Instrum., 41, 340– 345 (2005).
Y. Saeki, F. Atogami, K. Takahashi, and T. Yoshizawa, “Reflex control of autonomic function induced by posture change during the menstrual cycle,” J. Auton. Nerv. Syst., 66, Nos. 1–2, 69–74 (1997), doi: 10.1016/ S0165-1838(97)00067-2.
N. Sato, S. Miyake, J. Akatsu, and M. Kumashiro, “Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle,” Psychosom. Med., 57, No. 4, 331–335 (1995).
A. Yildirir, G. Kabakci, E. Akgul, et al., “Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability,” Ann. Noninvasive Electrocardiol., 7, No. 1, 60–63 (2002), doi: https://doi.org/10.1111/j.1542-474X.2001.tb00140.x.
E. W. Freeman, U. Halbreich, G. S. Grubb, et al., “An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome,” Contraception, 85, No. 5, 437–445 (2012), doi: https://doi.org/10.1016/j.contraception.2011.09.010.
L. M. Lopez, A. A. Kaptein, and F. M. Helmerhorst, “Oral contraceptives containing drospirenone for premenstrual syndrome,” Cochrane Database Syst. Rev., 23, No. 1, CD006586 (2012), doi: 10.1002/14651858. CD006586.pub2.
C. Barth, A. Villringer, and J. Sacher, “Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods,” Front. Neurosci., 9, 37 (2015), doi: https://doi.org/10.3389/fnins.2015.00037.
T. Matsumoto, T. Ushiroyama, T. Kimura, et al., “Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome and premenstrual dysphoric disorder,” Biopsychosoc. Med., 1, 24 (2007), doi: https://doi.org/10.1186/1751-0759-1-24.
B. A. Pletzer and H. H. Kerschbaum, “50 years of hormonal contraception – time to find out, what it does to our brain,” Front. Neurosci., 8, 256, 1–6 (2014), doi: https://doi.org/10.3389/fnins.2014.0025.
T. Bäckström, M. Bixo, and J. Strömberg, “GABAA receptor-modulating steroids in relation to women’s behavioral health, Curr. Psychiatry Rep., 17, No. 11, 92 (2015), doi: 10.1007/s11920-015-0627-4.
V. De Leo, M. C. Musacchio, V. Cappelli, et al., “Hormonal contraceptives: pharmacology tailored to women’s health,” Hum. Reprod. Update, 22, No. 5, 634–646 (2016), doi: https://doi.org/10.1093/humupd/dmw016.
D. Shoupe and D. R. Mishell, “Oral contraceptives,” In: D. Shoupe and S. L. Kjos (Eds.), The Handbook of Contraception (pp. 13–43). Humana Press, Totowa, NJ (2016).
About this article
Cite this article
Danel, D.P., Kozak, K., Szala, A. et al. The Relationship between the Premenstrual Syndrome and Resting Cardiac Vagal Tone in Young Healthy Females: Role of Hormonal Contraception. Neurophysiology 51, 447–454 (2019). https://doi.org/10.1007/s11062-020-09841-w
- premenstrual syndrome (PMS)
- autonomic nervous system
- heart rate variability (HRV)
- cardiac vagal tone
- physiological wellbeing
- hormonal contraception